July 2025 in “Revista Eletrônica Acervo Científico” Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.
November 2024 in “RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218” Minoxidil is a safe and effective hair loss treatment, with pharmacists enhancing its benefits.
October 2024 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.
August 2024 in “RCMOS - Revista Científica Multidisciplinar O Saber” Barbershops should prioritize safe, responsible scalp care and refer clients to dermatologists when needed.
Early and accurate identification of primary scarring alopecias is crucial to prevent permanent hair loss.
June 2024 in “BioSCIENCE” Microinfusion of methotrexate can help treat frontal fibrosing alopecia.
May 2024 in “SPIRE - Sciences Po Institutional REpository” Understanding and treating alopecia areata improves patient care.
Baricitinib shows promise for treating alopecia areata with mild side effects.
August 2023 in “Anales de la Facultad de Ciencias Médicas” The patient with lupus and hair loss improved with oral and topical minoxidil.
Scalp lesions in discoid lupus are more common in women and linked to other autoimmune diseases.
February 2022 in “Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa” PRP is more effective than Minoxidil for reducing hair loss and promoting hair growth.
Microneedling is an effective way to treat hair loss from androgenetic alopecia.
Topical Minoxidil is effective for hair loss after COVID-19.
The review found that PRP is the most effective treatment for hair loss with few side effects.
Micro-needling with growth factors and minoxidil improved hair growth in a balding man.
September 2018 in “Open Repository of the University of Porto (University of Porto)” The internship highlighted the pharmacist's important role in health education and community engagement.
Two nutritional supplements improved hair growth and reduced hair loss in women with hair loss conditions.
Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.
August 2015 in “Dermatología Argentina” Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.
October 2014 in “Journal of the Portuguese Society of Dermatology and Venereology” Early recognition and treatment of LPP can prevent hair loss and improve quality of life.
January 2014 in “Revista del Centro Dermatológico Pascua” Cutaneous lupus can cause permanent hair loss by damaging hair follicles.
12 citations
,
October 2023 in “Journal of the European Academy of Dermatology and Venereology” Many people with skin conditions don't seek professional help, often due to self-management beliefs.
1 citations
,
April 2024 in “Dermatology Practical & Conceptual” Thick scalp melanoma can be hard to diagnose because it often looks like other skin conditions.
April 2023 in “Journal of Investigative Dermatology” New method measures skin cell turnover quickly and effectively, showing turnover slows with age and responds more to treatments in older skin.
9 citations
,
September 2015 in “Medical Clinics of North America” The document explains how to do skin procedures, care after surgery, and when to use certain treatments.
Atopic dermatitis affects the appearance of skin reactions, making certain features more common and improving diagnostic accuracy with dermoscopy.
December 2025 in “International Journal of Research in Dermatology” Keratosis pilaris is common in young females, and dermoscopy helps diagnose it accurately.
Skin changes can reveal serious hormone-related diseases, helping save lives.
May 2023 in “Experimental Dermatology” RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.
1 citations
,
January 2002 in “Journal of Clinical Dermatology” The document's conclusion cannot be provided because the document is not accessible or understandable.